Your Immune System Is Attacking Your Brain

50 Proteins You've Never Heard Of

Your body has a rapid-response defense system most people have never heard of. Over 50 proteins circulating in your blood, waiting. Bacteria gets in, complement tags it, inflammatory signals go out, immune cells show up to destroy whatever got flagged. Fast, effective, ancient.

In the brain, complement plays the same role. When cells get damaged — from injury, infection, whatever — complement proteins tag them for removal. Microglia, the brain's resident immune cells, respond to those tags. They show up at the damage site and start eating dead and dying cells. Clearing the wreckage. Necessary work.

The problem isn't that this system exists. The problem is what happens when it won't turn off.

When the Cleanup Crew Goes Rogue

A single concussion activates complement. Microglia mobilize, clear damaged tissue, inflammation resolves, the system resets. That's the design.

Repeated concussions break the reset.

Each new impact re-activates complement before the previous response has fully resolved. The cascade compounds. Inflammatory signaling stays elevated. And the microglia — which are supposed to clear debris and then stand down — become chronically activated. Aggressive. Indiscriminate.

Instead of just eating dead cells, they start stripping weakened but still-living neurons and synapses. Cells that took damage but could have recovered. Connections between brain regions that were bruised but not broken. The microglia tag them, engulf them, and destroy them anyway. Researchers call it synaptic stripping. It's one of the reasons cognitive problems persist long after the last hit.

The complement system doesn't know the difference between "damaged beyond repair" and "damaged but recovering." Once the tag goes on, the cleanup happens. And after repeated hits, the tagging threshold drops. More cells get flagged. More connections get severed. The brain's immune response becomes the thing doing the most damage.

The MUSC Study

In late 2025, a team at the Medical University of South Carolina published the first study looking at complement's role in mild, repetitive brain injuries specifically. Not severe TBI. Not single-impact models. The kind of repeated hits that happen in contact sports, military training, and years of heading a soccer ball.

"Most studies have focused on severe injuries. There were no studies specifically looking at the role of the complement system in these mild, repetitive injuries." — Dr. Silvia Guglietta, MUSC

The research team — led by Dr. Stephen Tomlinson and Dr. Guglietta, with Dr. Khalil Mallah as first author — developed a new animal model that mimics the repetitive mild impacts humans actually sustain. Then they tested what happens when you block complement activation using an experimental inhibitor called CR2-Crry.

CR2-Crry targets complement at the activation site. It doesn't suppress the entire immune system — it specifically dials down complement where it's causing damage in the brain. The results:

• Microglia became significantly less aggressive
• Synapses and neurons were better preserved
• Brain inflammation returned to normal levels
• Cognitive impairment improved
• Injured cells had a greater chance of recovery

The study was published in Signal Transduction and Targeted Therapy, a Nature journal. It focused on short-term outcomes, with long-term follow-up still underway to assess whether the protection holds against neurodegeneration.

Why This One Hits Different

I played competitive hockey, lacrosse, and football. Not one catastrophic hit. Years of them. The kind of contact where you don't get diagnosed with a concussion because you didn't lose consciousness, you didn't see stars, you just kept playing. Sub-concussive impacts, stacked over seasons and years.

That's exactly the injury pattern this study models.

Most TBI research has focused on the single severe event — the car crash, the IED blast, the knockout. That work matters. But it doesn't capture what happens to the brain of someone who absorbed hundreds or thousands of moderate impacts across a decade of contact sports. The damage isn't dramatic. It's cumulative. And until this study, nobody had shown that the complement system was a primary driver of why that cumulative damage keeps getting worse even after you stop playing.

The persistent cognitive issues — brain fog, slow processing, difficulty concentrating — aren't just scar tissue from old injuries. They're active, ongoing damage from an immune system that never stood down. Your microglia are still cleaning up. Still stripping connections. Years later.

What This Opens Up

CR2-Crry is experimental. You can't get it prescribed. This isn't a treatment you can access today. But the mechanism it reveals changes how we think about chronic post-concussion symptoms.

If a big chunk of long-term cognitive decline after repeated concussions is driven by the complement system still running hot — not just leftover damage from the original hits — then the damage isn't entirely in the past. It's happening now. And things that are happening now can potentially be stopped.

Complement-targeting drugs already exist for other conditions. The gap between "works in an animal model" and "available for humans" is real, but the distance is shorter than starting from zero.

The more immediate takeaway: anything that reduces chronic brain inflammation is working in the right direction. Sleep. Controlled exercise. Anti-inflammatory nutrition. Stress management. None of these target complement specifically, but they lower the overall inflammatory load that keeps the cascade running. This research gives a biological reason for why those interventions work — they're pulling the same lever from a different direction.

Assessment

For years, the assumption was that concussion damage was done at the moment of impact. You got hit, cells died, and whatever survived was what you had left. Recovery meant working with the remaining hardware.

This research says that's incomplete. After repeated concussions, the complement system keeps the damage going — actively removing cells and connections that could have survived. The immune response that's supposed to protect the brain becomes the thing destroying it.

That's not a hopeless finding. It's the opposite. Damage that's still actively happening is damage that can potentially be stopped. The MUSC team showed that blocking complement preserved neurons, protected synapses, and improved cognition. The biology responds to intervention.

The question isn't whether the mechanism is real. It's how fast we can get a complement inhibitor into human trials for repetitive mild TBI. Until then, every tool we have that reduces brain inflammation is buying time — keeping the complement cascade from doing more damage than it already has.